Biosimilars: Global Market, Trends and Competitor Analysis
Biosimilars: Global Market, Trends, and Competitor Analysis is a detailed analysis both of the market for biosimilars and for the market effects on pharmaceutical markets. The report provides a complete picture of the biosimilars market, including information on the world, United States, EU, Germany, France, UK, Italy Spain, rest of Europe, Russia, Japan, India, China, South Korea, Australia, Brazil, Mexico, Turkey, Iran, Canada and rest of world biosimilars market to 2022.
The report looks at the biosimilar market by application, including the autoimmune disease, blood disorder, cancer, diabetes and growth hormone deficiency biosimilar markets from 2006 to 2022. Biosimilars: Global Market, Trends, and Competitor Analysis also breaks down the biosimilars market by product type, including the following segments: biosimilar recombinant non-glycosylated protein market; biosimilar recombinant glycosylated protein market; monoclonal antibodies: biosimilar product sales; and biosimilar recombinant peptide and other product market from 2017 to 2022.
Biosimilars: Global Market, Trends, and Competitor Analysis provides a complete competitor analysis for 2017, by percentage of global market share. Eli Lilly, Pfizer and Sandoz are among the companies participating in this unique market and are profiled in the report.
The report draws six main market conclusions that involve patent protection, pricing, market participants, emerging markets, evolving market strategies and education.